as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
3.00%
Downside
2.79%
Upside
52 Week's Low
52 Week's High
50.27%
Downside
510.18%
Upside
Check Corbus Pharmaceuticals Holdings, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$116.4M
EPS (TTM)
-5.63
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-15.31
Industry PE ratio
-3.8535542168674697
P/B Ratio
0PEG Ratio
0EBITDA
-66.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
2230000.00%
Track how Corbus Pharmaceuticals Holdings, Inc. P/E has moved over time to understand its valuation trends.
Corbus Pharmaceuticals Holdings, Inc. in the last 5 years
Lowest (0.00x)
September 15, 2025
Today (-15.31x)
September 15, 2025
Industry (-3.85x)
September 15, 2025
Highest (-0.36x)
March 31, 2023
Today’s Price to Earnings Ratio: -15.31x
Compare market cap, revenue, PE, and other key metrics of Corbus Pharmaceuticals Holdings, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $116.4M | -83.93% | -15.31 | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Corbus Pharmaceuticals Holdings, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Corbus Pharmaceuticals Holdings, Inc. investment value today
Current value as on today
₹21,703
Returns
Returns from Corbus Pharmaceuticals Holdings, Inc. Stock
Dollar Returns*
₹4,985 (+4.99%)
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Corbus Pharmaceuticals Holdings, Inc.. Average target price of $40.67
Get share price movements and forecasts by analysts on Corbus Pharmaceuticals Holdings, Inc..
What analysts predicted
77.06%UPSIDE
Target Price
$40.67
Current Price
$9.33
Analyzed by
8 Analysts
Target
$40.67
Corbus Pharmaceuticals Holdings, Inc. target price $40.67, a slight upside of 77.06% compared to current price of $9.33. According to 8 analysts rating.
Search interest for Corbus Pharmaceuticals Holdings, Inc. Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:18% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 153.2%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 66.0%
Price Dip
In the last 1 year, CRBP stock has moved down by -82.6%
Organisation | Corbus Pharmaceuticals Holdings, Inc. |
Headquarters | 500 River Ridge Drive, Norwood, MA, United States, 02062 |
Industry | Health Technology |
CEO | Dr. Yuval Cohen Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Sean F. Moran CPA, M.B.A. | Chief Financial Officer |
Dr. Dominic Smethurst M.A., M.D. | Chief Medical Officer |
Dr. Ian Hodgson B.Sc., Ph.D. | Chief Operating Officer |
Mr. G. Scott Goeken J.D., M.S. | General Counsel & Corporate Secretary |
Ms. Christina Bertsch M.A. | Vice President of Human Resources |
Dr. Yuval Cohen Ph.D. | CEO & Director |
Corbus Pharmaceuticals Holdings, Inc. share price today is $9.33 as on at the close of the market. Corbus Pharmaceuticals Holdings, Inc. share today touched a day high of $9.59 and a low of $9.05.
Corbus Pharmaceuticals Holdings, Inc. share touched a 52 week high of $56.93 on and a 52 week low of $4.64 on . Corbus Pharmaceuticals Holdings, Inc. stock price today i.e. is closed at $9.33,which is 83.61% down from its 52 week high and 101.08% up from its 52 week low.
Corbus Pharmaceuticals Holdings, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Corbus Pharmaceuticals Holdings, Inc. (CRBP) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Corbus Pharmaceuticals Holdings, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Corbus Pharmaceuticals Holdings, Inc. share’s latest price of $9.33 as on September 16, 2025 at 1:29 am IST, you will get 1.0718 shares of Corbus Pharmaceuticals Holdings, Inc.. Learn more about
fractional shares .
Corbus Pharmaceuticals Holdings, Inc. stock has given -83.93% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?